Financials data is unavailable for this security.
View more
Year on year Boule Diagnostics AB grew revenues 4.24% from 548.09m to 571.33m while net income improved 96.24% from 12.73m to 24.98m.
| Gross margin | 45.14% |
|---|---|
| Net profit margin | -37.74% |
| Operating margin | -44.67% |
| Return on assets | -32.14% |
|---|---|
| Return on equity | -57.47% |
| Return on investment | -48.62% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Boule Diagnostics AB fell by 59.62m. However, the company earned 51.38m from its operations for a Cash Flow Margin of 8.99%. In addition the company used 82.71m on investing activities and also paid 25.51m in financing cash flows.
| Cash flow per share | -4.69 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 6.56 |
|---|---|
| Tangible book value per share | 2.28 |
More ▼
Balance sheet in SEKView more
| Current ratio | 1.04 |
|---|---|
| Quick ratio | 0.7686 |
| Total debt/total equity | 0.6995 |
|---|---|
| Total debt/total capital | 0.4116 |
More ▼
Growth rates in SEK
Year on year, growth in earnings per share excluding extraordinary items increased 42.22%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| Div yield(5 year avg) | 0.51% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -15.62 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -1,144.76 |
More ▼
